CW May 2000
Volume 9Issue Number 5 May 2000 ISSN 10593802 Hereditary Ovarian Cancer Patients Survive Longer than the Nonhereditary PatientsAdvanced-stage hereditary ovarian cancer patients with germline mutation of BRCA1 or BRCA2 gene survive longer than the sporadic cancer patients. This may be because the BRCA-mutated cancer cells respond well to chemotherapeutic agents that act by damaging DNA. Further, the underlying biological properties of the hereditary disease may cause the cells to grow slowly.
Go to Previous Page Go to Next Page Source & Additional Reading J. Boyd et al., Journal of the American Medical Association, May 3, 2000. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW May 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
